Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03306992 · ClinicalTrials.gov registry record · Phase 3
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study
A Phase 3 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 3
- Development phase
- 182
- Enrollment target
NCT03306992 is a Phase 3 study that has completed, run by University of Utah. The registered enrollment target is 182 participants.
The verdict
NCT03306992, a Phase 3 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 182 participants
- Enrollment target
Study Summary
This is a Phase 3 study aimed at investigating the effects of a personalized exercise program (PEP) in NSCLC patients (stage I, II, IIIa) and secondary lung cancer patients undergoing surgical treatment at the University of Utah and comparing the intervention to the current standard of care (no exercise program).
Interventions
- BEHAVIORAL Personalized Exercise Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2017-11-07 |
| Est. Completion | 2022-05-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03306992
The ClinicalTrials.gov registry entry for NCT03306992 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Personalized Exercise Program is the first listed.
NCT03306992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03306992 about?
NCT03306992 is a clinical study titled "Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study". This is a Phase 3 study aimed at investigating the effects of a personalized exercise program (PEP) in NSCLC patients (stage I, II, IIIa) and secondary lung cancer patients undergoing surgical treatment at the University of Utah and comparing the intervention to the current standard of care (no exer...
What is the current status of trial NCT03306992?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 182 participants. The study started on 2017-11-07. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT03306992?
The interventions under investigation include: Personalized Exercise Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03306992?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.